Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

In vitro and in vivo anti-angiogenic effects of hydroxyurea.

Lopes FC, Ferreira R, Albuquerque DM, Silveira AA, Costa R, Soares R, Costa FF, Conran N.

Microvasc Res. 2014 Jul;94:106-13. doi: 10.1016/j.mvr.2014.05.009. Epub 2014 Jun 9.

PMID:
24925859
2.

Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea.

Lopes FC, Traina F, Almeida CB, Leonardo FC, Franco-Penteado CF, Garrido VT, Colella MP, Soares R, Olalla-Saad ST, Costa FF, Conran N.

Haematologica. 2015 Jun;100(6):730-9. doi: 10.3324/haematol.2014.119727. Epub 2015 Mar 13.

3.

Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea.

Almeida CB, Souza LE, Leonardo FC, Costa FT, Werneck CC, Covas DT, Costa FF, Conran N.

Blood. 2015 Aug 6;126(6):711-20. doi: 10.1182/blood-2014-12-616250. Epub 2015 May 27.

4.

Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.

Huang W, Liang Y, Wang J, Li G, Wang G, Li Y, Chung HY.

Phytomedicine. 2016 Mar 15;23(3):283-92. doi: 10.1016/j.phymed.2015.12.021. Epub 2016 Jan 29.

PMID:
26969382
5.

Heme changes HIF-α, eNOS and nitrite production in HUVECs after simvastatin, HU, and ascorbic acid therapies.

da Guarda CC, Santiago RP, Pitanga TN, Santana SS, Zanette DL, Borges VM, Goncalves MS.

Microvasc Res. 2016 Jul;106:128-36. doi: 10.1016/j.mvr.2016.04.002. Epub 2016 Apr 14.

6.

Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis.

Ghim J, Moon JS, Lee CS, Lee J, Song P, Lee A, Jang JH, Kim D, Yoon JH, Koh YJ, Chelakkot C, Kang BJ, Kim JM, Kim KL, Yang YR, Kim Y, Kim SH, Hwang D, Suh PG, Koh GY, Kong YY, Ryu SH.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1697-703. doi: 10.1161/ATVBAHA.114.303416. Epub 2014 Jun 19.

7.

Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition.

Abusnina A, Keravis T, Zhou Q, Justiniano H, Lobstein A, Lugnier C.

Thromb Haemost. 2015 Feb;113(2):319-28. doi: 10.1160/TH14-05-0454. Epub 2014 Sep 18.

PMID:
25230992
8.

Alchornea glandulosa ethyl acetate fraction exhibits antiangiogenic activity: preliminary findings from in vitro assays using human umbilical vein endothelial cells.

Lopes FC, Rocha A, Pirraco A, Regasini LO, Siqueira JR, Silva DH, Bolzani VS, Carlos IZ, Soares R.

J Med Food. 2011 Oct;14(10):1244-53. doi: 10.1089/jmf.2010.0204. Epub 2011 Jun 11.

PMID:
21663472
9.
10.

Wen Luo Yin inhibits angiogenesis in collagen-induced arthritis rat model and in vitro.

Liu C, Kong X, Li X, Guo W, Zhang C, Sun Y, Su X, Liu X, Lu A, Lin N.

J Ethnopharmacol. 2013 Sep 16;149(2):478-89. doi: 10.1016/j.jep.2013.07.002. Epub 2013 Jul 16.

PMID:
23872253
11.

Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.

Chen MC, Lee CF, Huang WH, Chou TC.

Biochem Pharmacol. 2013 May 1;85(9):1278-87. doi: 10.1016/j.bcp.2013.02.009. Epub 2013 Feb 14.

PMID:
23416116
12.

Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.

Huang SW, Lien JC, Kuo SC, Huang TF.

Carcinogenesis. 2012 May;33(5):1022-30. doi: 10.1093/carcin/bgs127. Epub 2012 Mar 20.

PMID:
22436611
13.

Anti-angiogenic potential of an ethanol extract of Annona atemoya seeds in vitro and in vivo.

Yi JM, Park JS, Lee J, Hong JT, Bang OS, Kim NS.

BMC Complement Altern Med. 2014 Sep 23;14:353. doi: 10.1186/1472-6882-14-353.

14.

Response gene to complement 32, a novel hypoxia-regulated angiogenic inhibitor.

An X, Jin Y, Guo H, Foo SY, Cully BL, Wu J, Zeng H, Rosenzweig A, Li J.

Circulation. 2009 Aug 18;120(7):617-27. doi: 10.1161/CIRCULATIONAHA.108.841502. Epub 2009 Aug 3.

15.
16.

Coculture of stem cells from apical papilla and human umbilical vein endothelial cell under hypoxia increases the formation of three-dimensional vessel-like structures in vitro.

Yuan C, Wang P, Zhu L, Dissanayaka WL, Green DW, Tong EH, Jin L, Zhang C.

Tissue Eng Part A. 2015 Mar;21(5-6):1163-72. doi: 10.1089/ten.TEA.2014.0058. Epub 2014 Dec 23.

17.
18.

Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.

Hamsa TP, Kuttan G.

Eur J Pharmacol. 2010 Dec 15;649(1-3):64-73. doi: 10.1016/j.ejphar.2010.09.010. Epub 2010 Sep 19.

PMID:
20858484
19.

Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators.

Hamsa TP, Kuttan G.

Drug Chem Toxicol. 2012 Jan;35(1):57-70. doi: 10.3109/01480545.2011.589437.

PMID:
22145808
20.

Punarnavine, an alkaloid from Boerhaavia diffusa exhibits anti-angiogenic activity via downregulation of VEGF in vitro and in vivo.

Saraswati S, Alhaider AA, Agrawal SS.

Chem Biol Interact. 2013 Nov 25;206(2):204-13. doi: 10.1016/j.cbi.2013.09.007. Epub 2013 Sep 20.

PMID:
24060680

Supplemental Content

Support Center